Highly Leveraged NASDAQ Biotechnology Companies

Total Debt
Total DebtEfficiencyMarket RiskExp Return
1AMGN Amgen Inc
64.61 B
(0.15)
 1.69 
(0.25)
2AZN AstraZeneca PLC ADR
28.62 B
(0.27)
 1.53 
(0.41)
3GILD Gilead Sciences
24.99 B
 0.19 
 1.42 
 0.27 
4SNY Sanofi ADR
18.42 B
(0.18)
 1.22 
(0.22)
5VTRS Viatris
18.37 B
 0.07 
 2.29 
 0.17 
6GRFS Grifols SA ADR
10.12 B
(0.07)
 2.88 
(0.19)
7BIIB Biogen Inc
7.34 B
(0.29)
 1.33 
(0.38)
8RPRX Royalty Pharma Plc
6.14 B
(0.12)
 1.00 
(0.12)
9JAZZ Jazz Pharmaceuticals PLC
5.79 B
 0.05 
 2.08 
 0.11 
10REGN Regeneron Pharmaceuticals
2.7 B
(0.40)
 1.73 
(0.70)
11ALNY Alnylam Pharmaceuticals
2.68 B
(0.01)
 2.21 
(0.03)
12ILMN Illumina
2.26 B
 0.08 
 2.30 
 0.18 
13PTCT PTC Therapeutics
2.23 B
 0.12 
 3.64 
 0.45 
14BBIO BridgeBio Pharma
1.74 B
 0.01 
 3.69 
 0.04 
15FTRE Fortrea Holdings
1.68 B
 0.00 
 5.07 
 0.01 
16HALO Halozyme Therapeutics
1.5 B
(0.09)
 3.83 
(0.36)
17IONS Ionis Pharmaceuticals
1.45 B
(0.16)
 2.65 
(0.41)
18SRPT Sarepta Therapeutics
1.4 B
 0.02 
 2.68 
 0.06 
19GH Guardant Health
1.35 B
 0.15 
 3.89 
 0.58 
20MRNA Moderna
1.24 B
(0.24)
 3.60 
(0.85)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively. In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.